EuropaWire

EQT Life Sciences Backs Exciva with €51 Million Financing to Address Unmet Needs in Alzheimer’s Care

EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, ...

Your Ray-Ban Meta alternative is open-source, and that changes everything

Mentra Live is a Ray-Ban Meta alternative with a rare perk, an open-source OS and a MiniApp Store. It’s limited-run, ...

Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of the first head-to-head data comparing vesicular monoamine transporter 2 (VMAT2) target occupancy between INGREZZA® ...

Soleno Therapeutics (SLNO) Receives a Buy from Wells Fargo

Detailed price information for Soleno Therapeutics Inc (SLNO-Q) from The Globe and Mail including charting and trades.

Samsung XR smart glasses leak says you may see two versions

Samsung XR smart glasses may launch in two versions. A leak cites model numbers SM-O200P and SM-O200J, plus a 12MP autofocus ...